Introduction 
Gynaeco-oncologists associated in the BNGO conduct routine patient surveys on symptom burden and satisfaction with cancer treatment. The current survey includes the NCCN distress thermometer.
Objectives
To monitor the quality of life of patients with gynaecologic tumors and their satisfaction with their treatment in BNGO practices. 
Methods
Since August 2017, 1116 patients have completed a printed questionnaire on the distress they are experiencing, tumor- and treatment-related symptoms, and their satisfaction with the practice and the physician. Chemotherapy patients also reported the frequency of side effects and rated the most distressing on a scale of 1 (least) to 10 (most). 
Results
On the 11-point scale of the NCCN distress thermometer (0= no distress, 10= extreme distress) 66% circled numbers between 0 and 5 (moderate). 99% of patients said the practice staff was very good or good and 100% rated their treating physician as very good or good. 34% of all patients perceived fatigue as the most distressing symptom, followed by problems sleeping (33%). 69% of patients received chemotherapy. 83% of them reported alopecia, followed by fatigue (54%). 47% of chemotherapy patients considered bone pain and 44% alopecia an extremely distressing or the most distressing symptom. After the end of chemotherapy, 36% of patients still reported fatigue and 34% still experienced peripheral neuropathy.
Conclusions
Symptoms preventable by supportive care medications such as vomiting are rare. Peripheral neuropathy and fatigue often persist after the end of chemotherapy. Patients are well satisfied with their cancer treatment in BNGO practices.

10 / PATIENT REPORTED SYMPTOMS OF CANCER TREATMENT AND PATIENT SATISFACTION IN BNGO PRACTICES – A GERMAN SURVEY INCLUDING THE NCCN DISTRESS THERMOMETER